ioversol has been researched along with Adrenal Cancer in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ioversol was well tolerated in the study with only two mild adverse reactions (nausea and vomiting, and metallic taste)." | 2.67 | [Evaluation of diagnostic efficacy and clinical tolerability of ioversol in "whole body" computed tomography in children. A non comparative phase III trial]. ( Bourlière-Najean, B; Devred, P; Faure, F; Le Bail, C; Panuel, M; Ternier, F, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Panuel, M | 1 |
| Devred, P | 1 |
| Faure, F | 1 |
| Bourlière-Najean, B | 1 |
| Ternier, F | 1 |
| Le Bail, C | 1 |
1 trial available for ioversol and Adrenal Cancer
| Article | Year |
|---|---|
[Evaluation of diagnostic efficacy and clinical tolerability of ioversol in "whole body" computed tomography in children. A non comparative phase III trial].
Topics: Adolescent; Adrenal Gland Neoplasms; Child; Child, Preschool; Female; Humans; Infant; Injections, In | 1992 |